Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women with Type 2 Diabetes Mellitus - Bilezikian, JP; Josse, RG; Eastell, R; Lewiecki, EM; Miller, CG; Wooddell, M (J Clin Endocrinol Metab, 2013)
et al.